Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the Confirmation Certificates issued by KFin Technologies Limited, Registrar and Share Transfer Agents of the Company, for the quarter ended September 30, 2022. Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed News Release of our company titled 'Casper Pharma Receives EIR from USFDA for its PAI (pre-approval inspection)'. Suven Pharmaceuticals Ltd - 543064 - Closure of Trading Window
We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st October, 2022 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter/half-year ending 30th September, 2022, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Suven Pharmaceuticals Ltd - 543064 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from shareholder of the Company, regarding loss of share certificate(s) as details mentioned below. A copy of intimation from Shareholder is enclosed herewith. Name of the Holder Folio No. No. of Shares Certificate No.(s) Distinctive Nos. date of receipt of information From To GUMAN MAL JAIN SPC0164189 1000 164189 127242479 127243478 21/09/2022 1000 277064 254529957 254530956 The Company is in process of issuing 'Letter of Confirmation' in lieu of the original share certificate(s), after completion of required formalities.
This multibagger stock shall pay 600% dividend soon: Do you own it?
Suven Pharmaceuticals Ltd is a mid-cap company having a market cap of 12,504.23 Crore operating in the pharma sector Suven Pharmaceuticals Ltd - 543064 - Clarification /Confirmation On News Item Appearing In 'Media/Publication'
We refer to your email/letter cited under reference on the subject received through email, asking us clarify on the news item that appeared today in the 'Website-www.moneycontrol.com' dated September 07, 2022 captioned 'Suven Pharma on the block, in talks with PE, strategic firms for control deal.' Suven Pharmaceuticals Ltd - 543064 - Clarification sought from Suven Pharmaceuticals Ltd
The Exchange has sought clarification from Suven Pharmaceuticals Ltd on September 7, 2022, with reference to news appeared inwww.moneycontrol.com dated September 7, 2022 quoting "Suven Pharma on the block, in talks with PE, strategic firms for control deal."The reply is awaited. Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting
With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. September 02, 2022, approved the following matters. Interim Dividend a) The Board has declared an Interim Dividend of Rs.1.00 per equity share (100% of face value of Rs.1.00 each) and special dividend of Rs. 5.00 per equity share (500% of face value of Rs.1.00), totaling to Rs. 6.00 per equity share (600% of face value of Rs. 1.00 each) for the financial year 2022-23. b) The Board has approved the Record Date i.e., September 12, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from September 20, 2022. The Board Meeting commenced at 12:30 P.M. and concluded at 1:20 P.M. Suven Pharmaceuticals Ltd - 543064 - Corporate Action-Board approves Dividend
With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. September 02, 2022, approved the following matters. Interim Dividend a) The Board has declared an Interim Dividend of Rs.1.00 per equity share (100% of face value of Rs.1.00 each) and special dividend of Rs. 5.00 per equity share (500% of face value of Rs.1.00), totaling to Rs. 6.00 per equity share (600% of face value of Rs. 1.00 each) for the financial year 2022-23. b) The Board has approved the Record Date i.e., September 12, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from September 20, 2022. The Board Meeting commenced at 12:30 P.M. and concluded at 1:20 P.M. Suven Pharmaceuticals Ltd - 543064 - Board Meeting Outcome for Outcome Of The Board Meeting
With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. September 02, 2022, approved the following matters. Interim Dividend a) The Board has declared an Interim Dividend of Rs.1.00 per equity share (100% of face value of Rs.1.00 each) and special dividend of Rs. 5.00 per equity share (500% of face value of Rs.1.00), totaling to Rs. 6.00 per equity share (600% of face value of Rs. 1.00 each) for the financial year 2022-23. b) The Board has approved the Record Date i.e., September 12, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from September 20, 2022. The Board Meeting commenced at 12:30 P.M. and concluded at 1:20 P.M. This is for your information and record.